GDNF Gene Therapy for Multiple System Atrophy
GDNF Gene Therapy for Multiple System Atrophy
Active, not recruiting · NCT04680065 · Registry updated 2026-01-30Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| GDNF Gene Therapy for Multiple System Atrophy | autonomic nervous system disorder, basal ganglia disorder, brain disorder, central nervous system disorder, movement disorder, multiple system atrophy, nervous system disorder, neurodegenerative disease, primary dysautonomia, synucleinopathy | Active, not recruiting | Phase 1 | 2026-01-30 | NCT04680065 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Brain Neurotherapy Bio, Inc. | 2 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Massachusetts General Hospital | Boston | United States | 1015 |
| NYU Langone Health | New York | United States | 403 |
| Parkinson's Disease and Movement Disorders Center of Boca Raton | Boca Raton | United States | 12 |
| Quest Research Institute | Farmington Hills | United States | 47 |
| The Ohio State University Medical Center | Columbus | United States | 13 |
| University of California Irvine | Irvine | United States | 30 |
| Vanderbilt University Medical Center | Nashville | United States | 427 |